Literature DB >> 18263760

Steroid-responsive chronic cerebellitis with positive glutamate receptor delta 2 antibody.

Masaya Kubota1, Yukitoshi Takahashi.   

Abstract

We report the clinical course of a 4-year-old girl with chronic cerebellitis (onset 2 days after diphtheria-pertussis-tetanus vaccination at 1 year and 7 months old) associated with anti-glutamate receptor delta 2 antibody, who improved dramatically with steroid therapy (methylprednisolone pulse therapy plus oral prednisolone). Recently, it has been reported that the anti-glutamate receptor delta 2 selectively expressed at the post-synaptic site of parallel fiber-Purkinje cell synapses has an important role in cerebellar function in the developing brain. The present case suggests that anti-glutamate receptor delta 2 antibody plays a primary role in an immune-mediated process causing chronic cerebellar symptoms, and the lesion site seems to be localized to the parallel fiber-Purkinje cell synapse. Because the cerebellum is strongly involved in language acquisition as well as motor development, treatment must facilitate time for language learning while reducing the side effects of the corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263760     DOI: 10.1177/0883073807307973

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation.

Authors:  Ramona Miske; Stefanie Hahn; Thorsten Rosenkranz; Matthias Müller; Inga M Dettmann; Swantje Mindorf; Yvonne Denno; Stefanie Brakopp; Madeleine Scharf; Bianca Teegen; Christian Probst; Nico Melzer; Hans-Michael Meinck; Christoph Terborg; Winfried Stöcker; Lars Komorowski
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-07-14

2.  Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.

Authors:  Georgina Berridge; David A Menassa; Teresa Moloney; Patrick J Waters; Imogen Welding; Selina Thomsen; Sameer Zuberi; Roman Fischer; A Radu Aricescu; Michael Pike; Russell C Dale; Benedikt Kessler; Angela Vincent; Ming Lim; Sarosh R Irani; Bethan Lang
Journal:  Neurology       Date:  2018-07-25       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.